The emergence of multidrug-resistant Gram-negative bacteria that cause nosocomial
infections is a growing problem worldwide. Colistin was first introduced in 1952 and was …

Colistin is the last resort for treatment of multidrug-resistant Acinetobacter baumannii.
Unfortunately, resistance to colistin has been reported all over the world. The highest …

Polymyxins act by binding to lipid A moiety of the bacterial lipopolysaccharide and
subsequently disintegrating the bacterial membranes. The most important mechanism of …

Acinetobacter baumannii has been increasingly associated with hospital-acquired
infections, and the presence of multidrug resistance strains is of great concern to clinicians …

Multidrug-resistant (MDR) Acinetobacter baumannii infections have emerged as a serious
threat worldwide. As novel agents have yet to be developed, understanding the …

Clinicians nowadays are confronted with an epidemic of multidrug-resistant (MDR)
Acinetobacter infections and are forced to consider every treatment alternative, including …

The widespread use of antibiotics has been associated with the emergence of antimicrobial
resistance among bacteria.'ESKAPE'(Enterococcus faecium, Staphylococcus aureus …

Background Antimicrobial surveillance is important for providing an up-to-date
understanding of the epidemiology of antimicrobial resistance and for creating a forum for …

Purpose Colistin is used for the treatment of pneumonia associated with multidrug-resistant
Acinetobacter baumannii and Pseudomonas aeruginosa. However, the best route of …

Aim: To control the spread of Acinetobacter baumannii in hospitals, it is necessary to identify
the reservoir of organisms and the way they are transmitted. This study analyzed samples by …